JP, W., J, L., S, N., A, K., UH, S., & C, H. (2005). High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. Histopathology, 46(4), 380. https://doi.org/10.1111/j.1365-2559.2005.02073.x
Chicago Style (17th ed.) CitationJP, Wiksten, Lundin J, Nordling S, Kokkola A, Stenman UH, and Haglund C. "High Tissue Expression of Tumour-associated Trypsin Inhibitor (TATI) Associates with a More Favourable Prognosis in Gastric Cancer." Histopathology 46, no. 4 (2005): 380. https://doi.org/10.1111/j.1365-2559.2005.02073.x.
MLA (9th ed.) CitationJP, Wiksten, et al. "High Tissue Expression of Tumour-associated Trypsin Inhibitor (TATI) Associates with a More Favourable Prognosis in Gastric Cancer." Histopathology, vol. 46, no. 4, 2005, p. 380, https://doi.org/10.1111/j.1365-2559.2005.02073.x.